DTB podcast
Summary: From June 2023, all our podcasts will move to https://dtbbmj.podbean.com. You can continue with your subscription on your favourite podcast App. For 50 years, Drug and Therapeutics Bulletin (DTB) has provided rigorous and independent evaluations of, and practical advice on, individual treatments and the overall management of disease for doctors, pharmacists and other healthcare professionals. DTB has always been wholly independent of the pharmaceutical industry, Government and regulatory authorities. DTB is also free of advertising and other forms of commercial sponsorship. Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page - https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309. * The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.
- Visit Website
- RSS
- Artist: BMJ Group
- Copyright: 643134
Podcasts:
A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:The price you payManagement of corticosteroid-induced osteoporosisWhat role for Qlaira in contraception?A guide to health economic evaluationsDon’t Drop Mixtard 30 campaign
As part of DTB’s “Don’t Drop Mixtard” campaign, this podcast discusses the implications of the drug’s withdrawal from the UK market for people with diabetes, healthcare professionals and the NHS.The conversation involves Dr Wing May Kong (consultant endocrinologist and member of the DTB Editorial Board), Cathy Moulton (Care Adviser at Diabetes UK), and Dr Ike Iheanacho and David Phizackerley (Editor and Deputy Editor of DTB, respectively).To find out more about the campaign, including DTB’s petition against the withdrawal of Mixtard 30, please go to dtb.bmj.com.
As part of DTB’s “Don’t Drop Mixtard” campaign, this podcast discusses the implications of the drug’s withdrawal from the UK market for people with diabetes, healthcare professionals and the NHS.The conversation involves Dr Wing May Kong (consultant endocrinologist and member of the DTB Editorial Board), Cathy Moulton (Care Adviser at Diabetes UK), and Dr Ike Iheanacho and David Phizackerley (Editor and Deputy Editor of DTB, respectively).To find out more about the campaign, including DTB’s petition against the withdrawal of Mixtard 30, please go to dtb.bmj.com.
A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:Mixtard 30 - going, going, gone?Ulipristal – a new emergency contraceptive pillManagement of fibromyalgiaAgomelatine for major depressive episodes
A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:Mixtard 30 - going, going, gone?Ulipristal – a new emergency contraceptive pillManagement of fibromyalgiaAgomelatine for major depressive episodes
A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:Money, money, moneyPreventing exacerbations in COPDFebuxostat for goutHow medical devices are regulated in the UK
A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:Money, money, moneyPreventing exacerbations in COPDFebuxostat for goutHow medical devices are regulated in the UK
A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:Why pregabalin? DTB 2010; 48: 61Acupuncture for tension-type headaches and migraine DTB 2010; 48: 62 - 5Misoprostol for postpartum haemorrhage DTB 2010; 48: 66 - 9Testosterone for ‘late-onset hypogonadism’ in men? DTB 2010; 48: 69 - 72
A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:Why pregabalin? DTB 2010; 48: 61Acupuncture for tension-type headaches and migraine DTB 2010; 48: 62 - 5Misoprostol for postpartum haemorrhage DTB 2010; 48: 66 - 9Testosterone for ‘late-onset hypogonadism’ in men? DTB 2010; 48: 69 - 72
A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:Alcoholic neglect DTB 2010; 48: 49Liraglutide for type 2 diabetes? DTB 2010; 48: 50 - 3Grazax for hay fever – what’s new? DTB 2010; 48: 54 - 6I.V. immunoglobulin therapy for infectious diseases DTB 2010; 48: 57 - 60
A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:Alcoholic neglect DTB 2010; 48: 49Liraglutide for type 2 diabetes? DTB 2010; 48: 50 - 3Grazax for hay fever – what’s new? DTB 2010; 48: 54 - 6I.V. immunoglobulin therapy for infectious diseases DTB 2010; 48: 57 - 60
A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:The computer says “no”? DTB 2010; 48: 37Silver dressings – do they work? DTB 2010; 48: 38 - 42Vagus nerve stimulation for epilepsy DTB 2010; 48: 42 - 45Herbal medicines – what do clinicians know? DTB 2010; 48: 46 - 47
A monthly audio round-up detailing the contents of the latest issue of DTB.Articles:The computer says “no”? DTB 2010; 48: 37Silver dressings – do they work? DTB 2010; 48: 38 - 42Vagus nerve stimulation for epilepsy DTB 2010; 48: 42 - 45Herbal medicines – what do clinicians know? DTB 2010; 48: 46 - 47
This month, we publish the results of a Drug and Therapeutics Bulletin Survey on Herbal Medicines, an online research designed to explore healthcare professionals’ knowledge of and attitudes towards herbal medicines. In this podcast, Dr Ike Iheanacho, DTB Editor, and David Phizackerley, DTB Deputy Editor, discuss the results of the survey, and issues related to the use and regulation herbal medicines, with Dr Linda Anderson, Principal Pharmaceutical Assessor at the MHRA and Mr Michael McIntyre, Chairman of the European Herbal and Traditional Medicine Practitioners Association. The results of DTB Survey on Herbal Medicines are available on our website, dtb.bmj.com.
This month, we publish the results of a Drug and Therapeutics Bulletin Survey on Herbal Medicines, an online research designed to explore healthcare professionals’ knowledge of and attitudes towards herbal medicines. In this podcast, Dr Ike Iheanacho, DTB Editor, and David Phizackerley, DTB Deputy Editor, discuss the results of the survey, and issues related to the use and regulation herbal medicines, with Dr Linda Anderson, Principal Pharmaceutical Assessor at the MHRA and Mr Michael McIntyre, Chairman of the European Herbal and Traditional Medicine Practitioners Association. The results of DTB Survey on Herbal Medicines are available on our website, dtb.bmj.com.
